research

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal

Abstract

Evidence Review Group (ERG) final report for the National Institute for Health and Clinical ExcellencePublisher PD

    Similar works